Point your AI agent at freehire and let it find you a job.

Get the CLI →

Valo Health

Developing new medicines using an AI computational platform.

H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.
Discussion
aibiotechdata-analyticshealth-techpharmaceuticals

Company facts

Series C-stage
Founded
2019
Employees
204
Headquarters
United States
CEO
Brian M. Alexander
Type
Private
Funding
Series B · $110M · 2021
Subsidiaries
TARA Biosystems, Courier Therapeutics, Numerate, TrialzOWN

About

Valo Health is pioneering a new approach to drug discovery and development, leveraging vast amounts of human data and artificial intelligence through its Opal Computational Platform™. Recognizing the slow and costly nature of traditional drug development processes, Valo is committed to revolutionizing this landscape by uniting machine learning, tissue biology, and patient data. This integration not only streamlines the entire drug development lifecycle but also significantly enhances the success rates of new therapies. The company assembles a diverse team of experts encompassing fields such as software engineering, data science, biology, and medicinal chemistry. This multidisciplinary approach fosters innovative solutions that harness the power of human-centric data, ultimately facilitating the discovery of transformative medicines. Valo’s focus is particularly strong in areas like cardiovascular, metabolic, and oncological diseases, aiming to tackle high unmet medical needs.

2 jobs

Tailor your CV for this role?

We couldn't check your fit for this role — add a CV to your profile to see it next time.

A new version of freehire is available